Ads
related to: cologuard stool dna test for colon cancer
Search results
Results From The WOW.Com Content Network
On Friday, the FDA approved Exact Sciences Corp.’s (NASDAQ:EXAS) Cologuard Plus test, the company’s next-generation multi-target stool DNA test. The Cologuard Plus test is now approved for ...
In a separate study published Wednesday in the same journal, an updated version of the Cologuard stool test, which also looks for DNA fragments, seemed to improve its performance on false alarms ...
For comparison, the Cologuard stool sample kit costs around $500 and the average colonoscopy in the U.S. is $2,750, though insurance often covers screening for adults over 45.
Multi-targeted stool DNA test with fecal immunochemical testing (MT-sDNA, sDNA-FIT, or FIT-DNA): Cologuard, the only such test available in the U.S., requires a prescription.
Exact Sciences Corp. is an American molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer.
Stool DNA test (Cologuard): This screening kit looks for hidden blood, as well as altered DNA in your stool. Your doctor will order the test, and you will receive the collection kit in the mail.
Ad
related to: cologuard stool dna test for colon cancer